{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:53:16Z","timestamp":1793699596109,"version":"4.5.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006132","name":"US Department of Energy Office of Science","doi-asserted-by":"publisher","award":["DE-SC0022550"],"award-info":[{"award-number":["DE-SC0022550"]}],"id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"US Department of Energy Office of Science","doi-asserted-by":"publisher","award":["DE-SC0020958"],"award-info":[{"award-number":["DE-SC0020958"]}],"id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023051","name":"College of Arts and Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007904","name":"Texas A and M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"US Department of Energy","doi-asserted-by":"publisher","award":["DE-FG02-93ER4077"],"award-info":[{"award-number":["DE-FG02-93ER4077"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"US Department of Energy","doi-asserted-by":"publisher","award":["DE-NA0003841"],"award-info":[{"award-number":["DE-NA0003841"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008902","name":"Los Alamos National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.nucmedbio.2023.108387","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T21:04:28Z","timestamp":1695243868000},"page":"108387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply"],"prefix":"10.1016","volume":"126-127","author":[{"given":"Lauren A.","family":"McIntosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny E.","family":"Tereshatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Muzzioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noimat A.","family":"Jinadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela A.","family":"Picayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pisaneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Piwnica-Worms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel C.","family":"Tabacaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooklyn","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Lofton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tabacaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry J.","family":"Yennello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2023.108387_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2967\/jnumed.121.262687","article-title":"Harnessing alpha-Emitting Radionuclides for Therapy: Radiolabeling Method Review","volume":"63","author":"Yang","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0010","first-page":"13","article-title":"Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications","author":"Nelson","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0015","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s002590050306","article-title":"Radioimmunotherapy with alpha-emitting nuclides","volume":"25","author":"McDevitt","year":"1998","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1158\/1078-0432.CCR-12-0298","article-title":"Molecular pathways: targeted alpha-particle radiation therapy","volume":"19","author":"Baidoo","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/ract-2020-0016","article-title":"Astatine-211 labelled a small molecule peptide: specific cell killing in vitro and targeted therapy in a nude-mouse model","volume":"109","author":"Liu","year":"2021","journal-title":"Radiochimica Acta"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fonc.2013.00324","article-title":"The Potential and Hurdles of Targeted Alpha Therapy \u2013 Clinical Trials and Beyond","volume":"3","author":"Elgqvist","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0035","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.cclet.2022.03.025","article-title":"Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals","volume":"33","author":"Li","year":"2022","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0040","article-title":"211At and 125I-Labeling of (Hetero)Aryliodonium Ylides: Astatine Wins Again","volume":"28","author":"Maingueneau","year":"2022","journal-title":"Chemistry (Easton)"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2967\/jnumed.121.262098","article-title":"An Improved 211At-Labeled Agent for PSMA-Targeted \u03b1-Therapy","volume":"63","author":"Mease","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1874471011666180502104524","article-title":"An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth","volume":"11","author":"Morgenstern","year":"2018","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.nucmedbio.2007.03.007","article-title":"Targeted \u03b1-particle radiotherapy with 211At-labeled monoclonal antibodies","volume":"34","author":"Zalutsky","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0060","first-page":"425","article-title":"Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure","volume":"35","author":"Lindegren","year":"2020","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1874471011104030177","article-title":"Astatine-211: Production and Availability","volume":"4","author":"Zalutsky","year":"2011","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02164864","article-title":"The EDTA complexes of astatine","volume":"127","author":"Milesz","year":"1988","journal-title":"J Radioanal Nucl Chem Lett"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02162464","article-title":"Characterization of DTPA complexes and conjugated antibodies of astatine","volume":"137","author":"Milesz","year":"1989","journal-title":"J Radioanal Nucl Chem Lett"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1524\/ract.1992.56.4.173","article-title":"Nitrilotriacetate Complex of Univalent Astatine","volume":"56","author":"Schumann","year":"1992","journal-title":"Radiochimica Acta"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0085","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/0022-1902(68)80118-6","article-title":"The stability constants of chloride complexes of mono-valent astatine in nitric acid solution","volume":"30","author":"Norseyev","year":"1968","journal-title":"J Inorg Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.apradiso.2017.01.035","article-title":"(211)Rn\/(211)At and (209)At production with intense mass separated Fr ion beams for preclinical (211)At-based alpha-therapy research","volume":"122","author":"Crawford","year":"2017","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nucmedbio.2017.01.011","article-title":"Development of a preclinical (211)Rn\/(211)At generator system for targeted alpha therapy research with (211)At","volume":"48","author":"Crawford","year":"2017","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0020-708X(80)90125-8","article-title":"Excitation function for the nuclear reaction","volume":"31","author":"Meyer","year":"1980","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10967-019-06990-z","article-title":"Measurements of the excitation functions of radon and astatine isotopes from 7Li-induced reactions with 209Bi for development of a 211Rn\u2013211At generator","volume":"323","author":"Maeda","year":"2020","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nucmedbio.2021.05.007","article-title":"Production, purification and availability of 211At: Near term steps towards global access","volume":"100-101","author":"Feng","year":"2021","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.107.046938","article-title":"Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6","volume":"49","author":"Zalutsky","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2967\/jnumed.109.062604","article-title":"Intraperitoneal -Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab')2--A Phase I Study","volume":"50","author":"Andersson","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0125","article-title":"Astatine-211 based radionuclide therapy: Current clinical trial landscape","volume":"9","author":"Albertsson","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0130","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2967\/jnumed.120.261016","article-title":"Production and Supply of alpha-Particle-Emitting Radionuclides for Targeted alpha-Therapy","volume":"62","author":"Radchenko","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1524\/ract.2009.1590","article-title":"Extraction of astatine-211 in diisopropylether (DIPE)","volume":"97","author":"Alliot","year":"2009","journal-title":"Radiochimica Acta"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0145","doi-asserted-by":"crossref","first-page":"13923","DOI":"10.1021\/acs.inorgchem.0c01553","article-title":"Questioning the Affinity of Electrophilic Astatine for Sulfur-containing Compounds: Unexpected Bindings Revealed","volume":"59","author":"Bassal","year":"2020","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10967-020-07308-0","article-title":"Preparation of no-carrier-added 211At solutions by a simple dry distillation method in the 209Bi(4He, 2n)211At reaction","volume":"326","author":"Nishinaka","year":"2020","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0155","doi-asserted-by":"crossref","first-page":"12025","DOI":"10.1038\/srep12025","article-title":"Automated astatination of biomolecules \u2013 a stepping stone towards multicenter clinical trials","volume":"5","author":"Aneheim","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10967-017-5364-1","article-title":"Extraction of 211At from nitric acid solutions into various organic solvents for use as an \u03b1-source for radiation chemistry studies","volume":"314","author":"Ekberg","year":"2017","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0165","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/app3030636","article-title":"Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine","volume":"3","author":"Balkin","year":"2013","journal-title":"Appl Sci"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jlcr.1543","article-title":"Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extraction","volume":"51","author":"Bourgeois","year":"2008","journal-title":"J Label Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2020.117794","article-title":"Rapid recovery of At-211 by extraction chromatography","volume":"256","author":"Burns","year":"2021","journal-title":"Sep Purif Technol"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0180","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1021\/acs.inorgchem.0c00221","article-title":"A Solid-State Support for Separating Astatine-211 from Bismuth","volume":"59","author":"Woen","year":"2020","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0185","doi-asserted-by":"crossref","first-page":"20318","DOI":"10.1038\/s41598-019-56272-7","article-title":"Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets","volume":"9","author":"O\u2019Hara","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.apradiso.2017.02.001","article-title":"An automated flow system incorporating in-line acid dissolution of bismuth metal from a cyclotron irradiated target assembly for use in the isolation of astatine-211","volume":"122","author":"O\u2019Hara","year":"2017","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.136176","article-title":"Compact automated apparatus for rapid astatine recovery from nitric acid media: Design, application, and impurity characterization","volume":"442","author":"Tereshatov","year":"2022","journal-title":"Chem Eng J"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2023.124715","article-title":"Behavior of astatine and bismuth in non-conventional solvents: Extraction into imidazolium-based ionic liquid and methyl anthranilate with active pharmaceuticals binary mixtures from nitric acid media","volume":"326","author":"Tereshatov","year":"2023","journal-title":"Sep Purif Technol"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0205","doi-asserted-by":"crossref","first-page":"12037","DOI":"10.1039\/D3NJ01316B","article-title":"Ion exchange behavior of astatine and bismuth","volume":"47","author":"Tereshatov","year":"2023","journal-title":"New J Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.142742","article-title":"Mechanism of astatine and bismuth sorption on extraction chromatography resins from nitric acid media","volume":"464","author":"Tereshatov","year":"2023","journal-title":"Chem Eng J"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2021.120088","article-title":"Separation, speciation, and mechanism of astatine and bismuth extraction from nitric acid into 1-octanol and methyl anthranilate","volume":"282","author":"Tereshatov","year":"2022","journal-title":"Sep Purif Technol"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0220","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1021\/acs.inorgchem.2c00085","article-title":"Complexation of Astatine(III) with Ketones: Roles of NO(3)(-) Counterion and Exploration of Possible Binding Modes","volume":"61","author":"Burns","year":"2022","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0225","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1039\/D0CC03804K","article-title":"Astatine partitioning between nitric acid and conventional solvents: indication of covalency in ketone complexation of AtO+","volume":"56","author":"Burns","year":"2020","journal-title":"Chem Commun"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0230","doi-asserted-by":"crossref","first-page":"03002","DOI":"10.1051\/epjconf\/202125203002","article-title":"Advances in 211At production at Texas A&M University","volume":"252","author":"Yennello","year":"2021","journal-title":"EPJ Web of Conferences"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0235","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1021\/acs.orglett.8b00232","article-title":"Rapid Cu-Catalyzed [(211)At]Astatination and [(125)I]Iodination of Boronic Esters at Room Temperature","volume":"20","author":"Reilly","year":"2018","journal-title":"Org Lett"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0240","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acs.chemrev.5b00493","article-title":"(18)F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography","volume":"116","author":"Preshlock","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0245","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1021\/ja981075u","article-title":"Highly Stereocontrolled One-Step Synthesis of anti-\u03b2-Amino Alcohols from Organoboronic Acids, Amines, and \u03b1-Hydroxy Aldehydes","volume":"120","author":"Petasis","year":"1998","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0250","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/S0040-4039(98)00504-8","article-title":"New aryl\/heteroaryl CN bond cross-coupling reactions via arylboronic acid\/cupric acetate arylation","volume":"39","author":"Lam","year":"1998","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0255","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/jo991699y","article-title":"Simple, efficient catalyst system for the palladium-catalyzed amination of aryl chlorides, bromides, and triflates","volume":"65","author":"Wolfe","year":"2000","journal-title":"J Org Chem"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0260","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2967\/jnumed.118.213223","article-title":"PET Imaging of PARP Expression Using (18)F-Olaparib","volume":"60","author":"Wilson","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0265","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1038\/s41598-021-92476-6","article-title":"Synthesis of [(211)At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution","volume":"11","author":"Shirakami","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2023.108387_bb0270","article-title":"Radiation effects on ion-exchange resins. Part II. Gamma irradiation of Dowex","volume":"1","author":"Kazanjian","year":"1975"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805123000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805123000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:35:22Z","timestamp":1788467722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805123000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":53,"alternative-id":["S0969805123000756"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2023.108387","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2023.108387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108387"}}